![JPM | Free Full-Text | Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase | HTML JPM | Free Full-Text | Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase | HTML](https://www.mdpi.com/jpm/jpm-11-00250/article_deploy/html/images/jpm-11-00250-g001.png)
JPM | Free Full-Text | Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase | HTML
![Design of in vivo drug interaction studies: open-label, randomized,... | Download Scientific Diagram Design of in vivo drug interaction studies: open-label, randomized,... | Download Scientific Diagram](https://www.researchgate.net/publication/313690474/figure/fig1/AS:613858074959895@1523366578290/Design-of-in-vivo-drug-interaction-studies-open-label-randomized-3-way-crossover.png)
Design of in vivo drug interaction studies: open-label, randomized,... | Download Scientific Diagram
![Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation - Tornio - 2019 - Clinical Pharmacology & Therapeutics - Wiley Online Library Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation - Tornio - 2019 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/39551051-be03-45f7-84e6-80d98b49a679/cpt1435-fig-0001-m.jpg)
Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation - Tornio - 2019 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![Metformin Clinical DDI Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision | Absorption Systems Metformin Clinical DDI Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision | Absorption Systems](https://www.absorption.com/wp-content/uploads/2019/07/Proposed-Metformin-Study-Design.jpg)
Metformin Clinical DDI Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision | Absorption Systems
![An International Consensus List of Potentially Clinically Significant Drug- Drug Interactions in Older People - Journal of the American Medical Directors Association An International Consensus List of Potentially Clinically Significant Drug- Drug Interactions in Older People - Journal of the American Medical Directors Association](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a8031ec3-b00f-4273-8db9-9a31eb83812a/fx1_lrg.jpg)
An International Consensus List of Potentially Clinically Significant Drug- Drug Interactions in Older People - Journal of the American Medical Directors Association
![study design. Abbreviations: DDI, drug-drug interaction; Bbr, berberine... | Download Scientific Diagram study design. Abbreviations: DDI, drug-drug interaction; Bbr, berberine... | Download Scientific Diagram](https://www.researchgate.net/publication/329805742/figure/fig1/AS:705897051467782@1545310380332/study-design-Abbreviations-DDI-drug-drug-interaction-Bbr-berberine-chloride-Svt.png)
study design. Abbreviations: DDI, drug-drug interaction; Bbr, berberine... | Download Scientific Diagram
![Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials | BMC Cancer | Full Text Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-5076-0/MediaObjects/12885_2018_5076_Fig3_HTML.png)
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials | BMC Cancer | Full Text
![Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials | BMC Cancer | Full Text Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-5076-0/MediaObjects/12885_2018_5076_Fig2_HTML.png)
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials | BMC Cancer | Full Text
![The Pharmacokinetics of Gefitinib in a Chinese Cancer Population Group: A Virtual Clinical Trials Population Study - Journal of Pharmaceutical Sciences The Pharmacokinetics of Gefitinib in a Chinese Cancer Population Group: A Virtual Clinical Trials Population Study - Journal of Pharmaceutical Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/80b4051c-5604-49ff-9a35-c1e44ba99cd7/gr1_lrg.jpg)
The Pharmacokinetics of Gefitinib in a Chinese Cancer Population Group: A Virtual Clinical Trials Population Study - Journal of Pharmaceutical Sciences
![Study design of the drug-drug interaction clinical trial. MDZ stands... | Download Scientific Diagram Study design of the drug-drug interaction clinical trial. MDZ stands... | Download Scientific Diagram](https://www.researchgate.net/profile/Kayode-Ogungbenro/publication/23764983/figure/fig1/AS:310195357011968@1450967744213/Study-design-of-the-drug-drug-interaction-clinical-trial-MDZ-stands-for-Midazolam-SX.png)
Study design of the drug-drug interaction clinical trial. MDZ stands... | Download Scientific Diagram
![Clinical trial design. Notes: Inhibition study with fluconazole (A);... | Download Scientific Diagram Clinical trial design. Notes: Inhibition study with fluconazole (A);... | Download Scientific Diagram](https://www.researchgate.net/publication/315941347/figure/fig1/AS:624443961405440@1525890450070/Clinical-trial-design-Notes-Inhibition-study-with-fluconazole-A-induction-study-with.png)
Clinical trial design. Notes: Inhibition study with fluconazole (A);... | Download Scientific Diagram
![DDI study designs: study treatment and PK sampling during the PK cycle... | Download Scientific Diagram DDI study designs: study treatment and PK sampling during the PK cycle... | Download Scientific Diagram](https://www.researchgate.net/publication/319069819/figure/fig1/AS:526362328788992@1502505966261/DDI-study-designs-study-treatment-and-PK-sampling-during-the-PK-cycle-of-the-DDI-study.png)
DDI study designs: study treatment and PK sampling during the PK cycle... | Download Scientific Diagram
![Clinical Drug–Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access - Journal of Pharmaceutical Sciences Clinical Drug–Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access - Journal of Pharmaceutical Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5f6a7a82-fd5b-4a02-9354-334d688329d8/gr1_lrg.jpg)
Clinical Drug–Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access - Journal of Pharmaceutical Sciences
![Summary of literature search to identify trials with azole antifungal... | Download Scientific Diagram Summary of literature search to identify trials with azole antifungal... | Download Scientific Diagram](https://www.researchgate.net/publication/341554838/figure/fig2/AS:893795247874049@1590108801892/Summary-of-literature-search-to-identify-trials-with-azole-antifungal-drugs-in-DDI.png)
Summary of literature search to identify trials with azole antifungal... | Download Scientific Diagram
![Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan - ScienceDirect Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666027X21000232-ga1.jpg)
Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan - ScienceDirect
![Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model - Chen - 2019 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model - Chen - 2019 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/3b012215-fe73-4f89-b049-c907369616bf/psp412449-fig-0001-m.jpg)
Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model - Chen - 2019 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
![2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists | Bentham Science 2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdm/21/6/001.jpg)
2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists | Bentham Science
![Dihydroartemisinin-piperaquine for Human Immunodeficiency Virus (HIV) Infections Clinical Trial | Power Dihydroartemisinin-piperaquine for Human Immunodeficiency Virus (HIV) Infections Clinical Trial | Power](https://pwr-og-img.withpower.com/Apply%20to%20this%20Phase%204%20clinical%20trial%20treating%20Human%20Immunodeficiency%20Virus%20(HIV)%20Infections,%20HIV%20Infections,%20Drug%20Drug%20Interaction%20(DDI):%0A%0ADihydroartemisinin-piperaquine%20for%20Human%20Immunodeficiency%20Virus%20(HIV)%20Infections.png?md=1)